
### [MONDO:0019852](http://purl.obolibrary.org/obo/MONDO_0019852)
**Label:** non-acquired premature ovarian failure

**Subclasses:** [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0009299](http://purl.obolibrary.org/obo/MONDO_0009299) (46 XX gonadal dysgenesis), [MONDO:0019499](http://purl.obolibrary.org/obo/MONDO_0019499) (Turner syndrome), [MONDO:0018575](http://purl.obolibrary.org/obo/MONDO_0018575) (microcephalic primordial dwarfism-insulin resistance syndrome), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0010766](http://purl.obolibrary.org/obo/MONDO_0010766) (46,XX testicular disorder of sex development), 

**Corr. equiv. classes:** [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [Orphanet:881](http://www.orpha.net/ORDO/Orphanet_881), [Orphanet:243](http://www.orpha.net/ORDO/Orphanet_243), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [OMIM:233400](http://purl.obolibrary.org/obo/OMIM_233400), [OMIM:616138](http://purl.obolibrary.org/obo/OMIM_616138), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [OMIM:615300](http://purl.obolibrary.org/obo/OMIM_615300), [OMIM:233300](http://purl.obolibrary.org/obo/OMIM_233300), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:436182](http://www.orpha.net/ORDO/Orphanet_436182), [Orphanet:418](http://www.orpha.net/ORDO/Orphanet_418), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [OMIM:278850](http://purl.obolibrary.org/obo/OMIM_278850), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [OMIM:110100](http://purl.obolibrary.org/obo/OMIM_110100), [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:393](http://www.orpha.net/ORDO/Orphanet_393), [OMIM:300510](http://purl.obolibrary.org/obo/OMIM_300510), [OMIM:616541](http://purl.obolibrary.org/obo/OMIM_616541), [OMIM:300833](http://purl.obolibrary.org/obo/OMIM_300833), [OMIM:617253](http://purl.obolibrary.org/obo/OMIM_617253), [Orphanet:2855](http://www.orpha.net/ORDO/Orphanet_2855), [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [OMIM:614129](http://purl.obolibrary.org/obo/OMIM_614129), [OMIM:614324](http://purl.obolibrary.org/obo/OMIM_614324), [OMIM:611812](http://purl.obolibrary.org/obo/OMIM_611812), [Orphanet:126](http://www.orpha.net/ORDO/Orphanet_126), [OMIM:400045](http://purl.obolibrary.org/obo/OMIM_400045), [OMIM:614926](http://purl.obolibrary.org/obo/OMIM_614926), [Orphanet:2138](http://www.orpha.net/ORDO/Orphanet_2138), 

**Class expressions from DL-Learner:**

- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 55.54%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 55.54%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 53.73%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 52.90%
- Thing 52.88%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 52.88%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 52.13%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 51.71%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 51.13%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 49.42%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) 47.20%
- [HP:0000786](http://purl.obolibrary.org/obo/HP_0000786) (Primary amenorrhea) 46.40%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0010460](http://purl.obolibrary.org/obo/HP_0010460) (Abnormality of the female genitalia) 46.24%
- [HP:0000812](http://purl.obolibrary.org/obo/HP_0000812) (Abnormal internal genitalia) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 46.24%
- [HP:0000008](http://purl.obolibrary.org/obo/HP_0000008) (Abnormality of female internal genitalia) and [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) 46.24%


